Marlborough

RXi Pharmaceuticals, a clinical-stage drug company based in Marlborough, announced positive results from a clinical trial of its lead drug candidate, RXI-109.

The failure of Republicans in Congress this year to repeal the Affordable Care Act means that a controversial tax on medical device sales will return in 2018 unless legislators intervene in the next couple weeks, putting a major Bay State industry on edge.

Price Chopper in Hopkinton and Market 32 in Sutton are one of several of the chain's stores to begin a partnership with grocery delivery service Instacart on Wednesday.

RXi Pharmaceuticals Corp., a Marlborough clinical-stage company, has entered into a research collaboration with a German biotechnology company, Medigene.

The U.S. Food & Drug Administration has approved a new brain-stimulation Parkinson's disease implant from Marlborough medical device manufacturer Boston Scientific, the company announced Monday.

Lampin Corp., Provo Wealth Management and Worcester Art Museum are among the companies with recent hires and promotions.

Worcester-based UMass Memorial Health Care was profitable for a fourth straight year in the latest budget period but less so than the three previous years, system officials said.

The Massachusetts Department of Energy Resources has provided grants to eight energy-storage facilities in Central Massachusetts as part of a broader initiative.

Sunovion Pharmaceutics of Marlborough has received U.S. Food and Drug Administration approval for a new drug treating COPD, or chronic obstructive pulmonary disease.

The Astellas Institute for Regenerative Medicine, based in Marlborough, is moving to the Westborough Technology Park, according to the Westborough Economic Development Committee.